Logotype for Dexcom Inc

Dexcom (DXCM) investor relations material

Dexcom Baird Global Healthcare Conference 2025 summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Dexcom Inc
Baird Global Healthcare Conference 2025 summary10 Sep, 2025

Market performance and demand trends

  • Strong new patient growth continued in Q2, with momentum in both U.S. and international markets, though the U.S. leads in access and adoption.

  • Type 2 non-insulin and basal insulin segments are expanding rapidly, but type 1 and intensive type 2 growth remains consistent.

  • U.S. type 1 CGM penetration is estimated at 60–65%, with share win rates in basal insulin rising above 40%.

  • International markets lag the U.S. in access, but new coverage in places like Canada and emerging opportunities in Europe, Australia, and the Middle East are expected to drive future growth.

  • Market access teams are focused on unlocking new coverage, especially for basal and type 2 intensive populations.

Competitive landscape and product positioning

  • Integration with automated insulin delivery (AID) systems is a key differentiator, with over 2.6 million cumulative years of patient experience.

  • Concerns about competitor integration (e.g., Abbott/Medtronic) are minimal due to high loyalty and existing integrated solutions.

  • Dexcom Stelo and new coverage options are helping shift physician preferences in the non-insulin type 2 segment.

  • Compliance rates among new users, including broader populations, remain strong and stable.

  • Continuous product improvements, such as enhanced adhesive and Bluetooth range for G7, have reduced complaint rates.

Guidance, growth outlook, and strategic initiatives

  • 2025 is positioned as a year of execution, with raised guidance reflecting confidence in re-acceleration and momentum.

  • Strong double-digit growth is anticipated for 2026, contingent on successful execution and patient base expansion in 2025.

  • Expansion of coverage, especially in Medicare and commercial plans, is seen as a major catalyst for future growth.

  • The transition to a 15-day G7 sensor is underway, expected to accelerate through 2026, with per-member-per-month contracts protecting revenue per patient.

  • Vendor consolidation and competitive bidding in 2027–2028 are being monitored, with a focus on minimizing customer disruption and leveraging scale.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Dexcom earnings date

Logotype for Dexcom Inc
Q3 202530 Oct, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Dexcom earnings date

Logotype for Dexcom Inc
Q3 202530 Oct, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Dexcom, Inc., focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company's products include Dexcom G4 PLATINUM System, Dexcom G5 Mobile CGM System, and its interoperable systems, as well as other clinical diagnostic products. It offers its products to hospitals; physicians' offices specializing in diabetes treatment; ambulatory surgical centers; clinical practice settings; corporate wellness programs; and individual patients. The company markets its products directly to physicians and their specialties, including endocrinologists; general practitioners; obstetricians/gynecologists; pediatricians; family physicians; doctors practicing in health care clinics or managed facilities; diabetologists; and internists. The company was incorporated in 1999.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage